1 Min Read
Nov 7 (Reuters) -
* EOC Pharma Group says completed $32 million series B financing led by Taikang Investment through Shandong state-owned Taikang Industry Development Fund Source text for Eikon:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.